Prionics Acquires CEDI Diagnostics

Strategic Partnership With Life Science Innovation Centre

16-Mar-2006

Prionics announced the acquisition of CEDI-diagnostics. The Dutch firm is part of the Wageningen University and Research Centre (Wageningen UR). Through the purchase of CEDI, Prionics will acquire a substantial number of new products and gain rights to commercialise developments made by the research centre. Prionics and Wageningen UR have additionally agreed on a strategic partnership for the development of future innovations in farm animal diagnostics.

"We have acquired a firm with tests proven on the market and we gain access to future developments of a unique global research centre," says Dr Markus Moser, co-CEO of Prionics.

Other news from the department business & finance

Most read news

More news from our other portals

So close that even
molecules turn red...

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

1 products
1 whitepaper
1 brochures
View topic world
Topic world Diagnostics

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

1 products
1 whitepaper
1 brochures